# Neoantigen-Discovery-in-the-HCC1395-Breast-Cancer-Cell-Line
Pipeline for integrated whole-genome and transcriptome analysis to identify neoantigens in the HCC1395 breast cancer cell line. Combines somatic variant calling, RNA expression quantification, HLA typing, and neoantigen prediction for immunotherapy research.
